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Abstract
Background: Hypertension is an increasing health issue in sub-Saharan Africa where malaria remains common in pregnancy.
We established a birth cohort in Nigeria to evaluate the early impact of maternal malaria on newborn blood pressure (BP).
Methods: Anthropometric measurements, BP, blood films for malaria parasites and haematocrit were obtained in 436
mother-baby pairs. Women were grouped to distinguish between the timing of malaria parasitaemia as ‘No Malaria’, ‘Malaria
during pregnancy only’ or ‘Malaria at delivery’, and parasite density as low (,1000 parasites/ml of blood) and high ($1000/
ml).
Results: Prevalence of maternal malaria parasitaemia was 48%, associated with younger maternal age (p,0.001), being
primigravid (p=0.022), lower haematocrit (p=0.028). High parasite density through pregnancy had the largest effect on
mean birth indices so that weight, length, head and mid-upper arm circumferences were smaller by 300 g, 1.1 cm, 0.7 cm
and 0.4 cm respectively compared with ‘No malaria’ (all p#0.005). In babies of mothers who had ‘malaria at delivery’, their
SBPs adjusted for other confounders were lower respectively by 4.3 and 5.7 mmHg/kg compared with ‘malaria during
pregnancy only’ or ‘none’. In contrast the mean newborn systolic (SBP) and diastolic BPs (DBP) adjusted for birth weight
were higher by 1.7 and 1.4 mmHg/kg respectively in babies whose mothers had high compared with low parasitaemia.
Conclusions: As expected, prenatal malarial exposure had a significant impact on fetal growth rates. Malaria at delivery was
associated with the lowest newborn BPs while malaria through pregnancy, which may attenuate growth of the vascular
network, generated higher newborn BPs adjusted for size. These neonatal findings have potential implications for
cardiovascular health in sub-Saharan Africa.
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Introduction
Hypertension is now a public health and economic problem in
Sub-Saharan Africa with a prevalence up to 33% in urban areas in
Nigeria [1,2]. Its well-known complications and mortality occur at
a younger age than in developed countries [3,4]. In sub-Saharan
Africa, malaria is hyperendemic, particularly in pregnancy with
prevalence rates from 20 to 44% in Nigerian women [5]. Most
cases of malaria in pregnancy are asymptomatic because of
immunity acquired during previous exposures [5,6]. However,
asymptomatic infection still has significant consequences for
maternal and infant health resulting in maternal anaemia and
intrauterine growth retardation (IUGR), which causes 43% of
preventable low birth weight babies (LBW, birth weight ,2500 g),
contributing to 75,000–200,000 infant deaths each year [7–9]. In
Nigeria about 12–24% of newborns are LBW as a result of IUGR
[10,11].
In numerous global studies, adult risk of hypertension and other
chronic disease is associated with LBW [12,13]. In an emerging
economy, LBW babies who show catch-up growth may be at
particular risk of developing such disease in midlife [14]. These
observations subsequently led to the ‘developmental origins’
hypothesis.
In newborns, their blood pressure (BP) correlates with birth
weight [15–17]. There may be differences in the relationship
between birth weight and BP in preterm babies small (SGA) and
appropriate for gestational age (AGA) in the first week of life [18].
AGA babies showed the expected positive correlation between
birth weight and BP while SGA babies did not [18]. There are
limited data on newborn BP in African children, in particular
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exposure to malaria in utero.
Therefore, we tested the hypothesis that BP at birth would be
higher and birth size would be smaller in babies whose mothers
had malaria in pregnancy, defined by its timing during pregnancy
and/or at delivery and the magnitude of parasite density. This in
turn may affect the rate of BP rise through childhood and set the
scene for hypertension in later life.
Methods
Ethics Statement
Ethical approval was obtained from the joint University of
Ibadan / University College Hospital Ethics committee and the
University of Manchester Ethics committee. The study protocol
and the rationale for the study were explained carefully in
appropriate language, most commonly Yoruba or English, with
questions answered as needed and written informed consent was
obtained from all participants. After the delivery of their babies,
another written informed consent was also obtained for the
participation of their babies in the study.
Study Site
A semi-urban community, Yemetu-Adeoyo, Ibadan in South-
west Nigeria, where malaria transmission is perennial, was the site
for the study. Families come from a range of socioeconomic
backgrounds. The local community hospital, Adeoyo Maternity
Hospital (AMH), the oldest maternity hospital in Nigeria dating
from 1927, provides primary and secondary medical care with
over 4000 deliveries each year.
Participants
Healthy women aged 18–45 years presenting at AMH before 36
weeks gestation and residing within the catchment area of the
study centre for at least 2 years were recruited. Singleton babies
born at $37 weeks gestation were included.
At booking, women were tested for sexually transmitted
infections and HIV and those positive were excluded and those
with chronic diseases such as hypertension and diabetes. Preterm
deliveries, babies with known syndromes, metabolic defects,
congenital abnormalities or severe birth trauma were excluded.
Women were enrolled over one year to cover both wet and dry
seasons.
In the year, 3496 women booked for ante-natal care, but many
were not planning their delivery at AMH so 659 women were
eligible, of which 624 were recruited but 161 still did not deliver at
AMH; thus the final cohort included 463 mother-baby pairs. Of
these, 27 were excluded due to 4 (0.9%) maternal deaths, 11
(2.4%) still births, 5 (1.1%) miscarriages and 7 (1.5%) neonatal
deaths, leaving 436 pairs. There were no significant differences in
the socio-demographic and clinical data of excluded women.
Procedures: Time points and measurements
Standard operating procedures (SOPs) were developed. In-
formed consent, using forms translated into Yoruba, was taken at
booking, then demographic, obstetric, family and health details,
malarial history and use of antimalarial drugs was recorded. All
women were issued with prescriptions for sulphadoxine-pyrimeth-
amine (SP) for Intermittent Preventive Therapy (IPT) for malaria
according to standard hospital practice.
Maternal Anthropometry. Standardized measures of anth-
ropometry and BP were taken at every antenatal visit until
delivery, weight to the nearest 0.1 kg (SECA scale), height on a
stadiometer to the nearest 0.1 cm, both without shoes, according
to the SOP and training video.
Blood Samples. At each visit throughout pregnancy, 2 ml of
blood was obtained in EDTA tubes for haematocrit, leukocyte
count and blood film for MP. For haematocrit, a capillary tube
was filled to about 80% with blood, sealed with a flame and
centrifuged for 5 minutes at 10,000 revolutions per minute. The
haematocrit value was read with a heamatocrit reader. For the
leucocyte count, anticoagulated blood at a one in 20 dilution in
turk’s solution was mixed for about 1 minute and placed in the
counting chamber. The sample was left to settle, and the white
cells were counted using a microscope (106objective lens) in the
four outer 1 mm
2 areas. Total leucocyte number was calculated as
506the number of cells counted.
Blood films were prepared, stained with 3% Giemsa at pH 7.2
and examined for malaria parasites (MP) under light microscopy.
Thick smears were recorded as negative only after 200 high-power
microscope fields had been scanned. In those with malaria,
absolute parasite counts were determined as previously reported
[19] by counting the number of parasites (np) among 200
leucocytes on the thick film as follows: Absolute parasite counts
(per microlitre of blood)=(np / 200)6TLC where TLC=subject’s
total leucocyte count).
For quality control, 30% of negative samples and 40% of
positive samples were re-examined by two different trained
microscopists.
Follow-up, Delivery and Recruitment of Babies
Women were followed up until delivery based on routine ante-
natal practice, determined by gestational age. Repeat MP blood
films were obtained every visit and at delivery when a film was also
prepared from cord blood. The placenta was weighed, turned to
the maternal surface, cotyledons exposed and 1 ml of blood
obtained from the intervillous space for a placental malarial blood
smear. Detailed delivery information was recorded.
Newborn Anthropometry and Skinfold Measures. Babies
were weighed naked to the nearest 0.1 kg, length was measured
from crown to heel on an infant stadiometer to the nearest 0.1 cm
and occipito-frontal circumference (OFC) around the widest
circumference of the head using a non-stretchable tape to the
nearest 0.1 cm. Skinfold thicknesses (triceps, biceps, sub-scapular,
and suprailiac) were measured using Holtain calipers on the left
side to the nearest 0.1 mm. Measurements were obtained in
duplicate or triplicate if disagreeing by .15%. All babies were
examined within 72 hours of birth.
Maternal and Newborn BP. Maternal and newborn BPs
were taken according to a standard protocol and SOP. Before the
BP reading, the woman was comfortably seated and relaxed with
the back and arm supported, the legs uncrossed, for at least
5 minutes and not moving or speaking. Her upper arm was
supported at the level of the heart with no tight clothing
constricting the arm. The measurement was carried out on the
left arm with validated Datascope BP monitor using appropriate-
sized cuffs (i.e. the bladder length and width of the cuff supplied
were $80% and 40%, respectively, of the arm circumference).
Before performing the BP reading, the baby was comfortably
lying on the mother’s lap for at least 5 minutes, and many times
they were asleep. The measurement was again done with the
Datascope BP monitor, specifically validated for infants, using
appropriate newborn cuffs on the left arm. Babies were measured
within 72 hours of life. In both mother and child, measurements
were repeated three times at least one minute apart and the mean
of the last two readings used for analysis.
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nurses trained in anthropometry and BP methods, based on the
WHO manual (1995) and SOPs, carried out all measurements
throughout the study on the same equipment. Inter-observer and
within-observer error were minimized through 3-monthly refresher
training sessions.
Definitions
Anaemia was defined as packed cell volume (PCV),30%.
Malaria was defined as asexual blood stages of Plasmodium
falciparum in peripheral blood or placenta of the pregnant women
or cord blood at delivery. All visits during pregnancy and at
delivery were taken into account.
For this study, women were first grouped into 2 categories:
a) ‘No Malaria’ - no parasites detected throughout pregnancy or
at delivery (n=225).
b) ‘Malaria present’ - parasites present at least once during
pregnancy and/or at delivery (n=211).
Women with malaria were then stratified to distinguish between
the timing of malaria through all visits in pregnancy and at delivery:
a) ‘Malaria during pregnancy only’ - presence of malaria
parasites at least once during pregnancy but not at delivery
(n=138).
b) ‘Malaria at delivery’ - mothers with parasites present in the
placenta and/or their peripheral blood sample at delivery
and/or in the cord blood (n=73).
To examine effects of parasite load during pregnancy and at
delivery, parasite density was classified into low (,1000 parasites/
ml), or high ($1000/ml) based on the highest density recorded at
any time point’.
Statistical Analysis
Data were analysed using SPSS version 14 (SPSS Inc, Chicago,
IL). Socioeconomic index scores were based on occupations and
educational attainment of both parents on scales I to V, as
previously [20]. Means of the four scores to the nearest whole
number were assigned. Associations between categorical variables
and malaria status were assessed using Chi-square tests and Odds
Ratios. Differences in infant growth characteristics and blood
pressure at birth were assessed using t-tests and ANOVA. Based
on the results from the t-tests and ANOVA, multiple regression
methods were used to determine which factors were independent
predictors of birth weight, length, SBP and DBP. Malaria timing
and parasite density were entered into the regression model as
categorical variables with dummy variables. Based on the results
from the univariate analyses, we have used parasite density in the
regressions for birth weight and length and we have used malaria
timing in the regressions for newborn SBP and DBP. Two-sided P
values,0.05 were considered significant.
Results
Clinical characteristics of mothers and malaria status
All women recruited had at least 2 antenatal clinic attendances,
94% attended 3 times, 80% four times and 63% five times before
delivery. The median (range) durations of the pregnancy at
booking and at delivery were 28 (12–36) and 39 (37–42) weeks
respectively with 28% of women being primigravida.
Parasitaemia was present at least once in pregnancy and/or
delivery in 211 of the 436 recruited mothers (total 48%, with 30%
having low parasitaemia and 18% high parasitaemia). Classified
by timing, 138 (31%) had malaria parasitaemia at some time during
pregnancy only and 73 (17%) at delivery.
56% of those with parasitaemia were primigravid, so malaria
and first pregnancy were significantly associated (X
2=5.276,
p=0.022) and associated with nearly a 3-fold increase in risk of
having malaria (OR=2.5, 95% CI, 1.5–4.2).
About half of the women reported the use of preventive measure
such as chemoprophylaxis / insecticide spray or coil / bed nets /
netted windows but these were not associated with protection from
malaria (p.0.05). Social class and maternal malaria parasitaemia
were also not associated (X
2=1.557, p=0.212).
Most women were asymptomatic. A complaint of fever in the
week preceding recruitment and at every visit until delivery was
reported in 9 women and fever recorded in only 6 women.
Women with malaria had lower gravidity (p=0.005), they were
younger (27.7 vs 29.4 years, p=0.001) and more likely to be
anaemic than those without parasitaemia (Table 1). Malaria
parasitaemia and anaemia was found in 19% of all women, but
anaemia was present in 32%. Mean (SD) PCV was 32.2 (2.9)% in
women without malaria, 31.9 (3.4)% in those with low
parasitaemia and 30.7(3.6)% in those with high parasitaemia
(p=0.003).
Table 1. Clinical Characteristics of Mothers at recruitment by Malarial Status.
Parameter Malaria Absent n=225 (52%) Malaria present n=211 (48%)
Mean SD Mean SD t test P value
Age (years) 29.4 4.8 27.7 5.1 3.50 0.001
Gravidity 1.9 1.6 1.5 1.3 2.80 0.005
GA at booking (weeks) 27.3 4.9 26.7 5.4 0.89 0.374
Body temperature (uC) 37.1 0.6 37.2 0.6 0.01 0.992
Weight ( kg) 64.5 11.5 63.9 10.8 0.53 0.596
Height (cm) 160.4 5.9 160.1 5.3 0.52 0.600
SBP (mmHg) 104.0 9.4 104.2 7.7 20.20 0.840
DBP (mmHg) 60.9 7.2 61.0 6.7 20.10 0.921
Packed cell volume (%) 32.2 2.9 31.5 3.5 2.21 0.028
GA – Gestational Age; SBP – Systolic blood pressure; DBP- Diastolic blood pressure.
doi:10.1371/journal.pone.0024548.t001
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as pregnancy duration at booking, weight, height, body temper-
ature, SBP and DBP in women with and those without malaria
(Table 1).
Clinical characteristics of babies and malarial status:
parasite density compared with timing
Growth variables. Anthropometric variables and skinfolds
of infants born to women with malaria parasitaemia were globally
lighter than those of women without (Table 2 and 3a).
Based on parasite density, birth weight, length, OFC, and MUAC
of newborns born to women with high parasitaemia were smaller
by 300 (95% CI 100–400)gm, 1.1 (0.5–1.6)cm, 0.7 (0.3–1)cm and
0.4 (0.2–0.6)cm respectively compared with those without
parasitaemia (Table 3a). Skinfold thicknesses (biceps, triceps and
subscapular) were also smaller than those whose mothers had low
parasitaemia (Table 3a and 4a).
Analysis by malaria timing showed that parasitaemia at delivery
had no additional impact on anthropometric variables compared
to parasitaemia during pregnancy only (Table 3b).
Regression analyses testing effects on growth parameters
showed that birth length, gestational age at birth and maternal
weight were each independently associated with birth weight,
while high parasite density was inversely related (Table 5). Only
birth weight was independently related to birth length with no
effect of malarial status (Table 5).
Impact of maternal malaria parasitaemia on Newborn
BP. Babies whose mothers had no parasitaemia had higher
mean SBP (p=0.02) and DBP (p=0.049) than those with
parasitaemia (Table 2). This effect can be attributed to malaria
timing: babies whose mothers had parasitaemia at delivery had
SBP lower by 4.3 (0.6–8.0)mmHg/kg than those of women with
parasitaemia in pregnancy only, and 5.7 (0.8–8.9)mmHg/kg lower
than those without parasitaemia (Table 4b).
In contrast when evaluating the effect of parasite density
through pregnancy (Table 4a), mean SBP and DBP were not
Table 2. Associations between maternal malarial status,
newborn growth characteristics and newborn blood pressure
at birth.
Parameter
Malaria
Absent
n=225
Malaria
Present
n=211
Mean SD Mean SD t test p value
Weight (kg) 2.97 0.4 2.85 0.4 2.72 0.007
Length (cm) 48.97 2.4 48.35 2.1 2.82 0.005
OFC (cm) 34.5 1.4 34.2 1.2 2.21 0.028
MUAC (cm) 9.95 0.8 9.77 0.9 2.11 0.036
Subscapular (cm) 4.28 0.9 4.14 0.8 1.67 0.097
Suprailiac (cm) 4.42 0.9 4.27 0.9 1.60 0.111
Triceps (cm) 4.19 0.8 4.08 0.9 1.28 0.200
Biceps (cm) 3.70 0.8 3.55 0.6 2.15 0.032
Subscap/Triceps Ratio 1.03 0.1 1.02 0.1 0.13 0.899
SBP (mmHg) 72.4 13.4 69.5 12.2 2.34 0.020
DBP (mmHg) 37.0 9.5 35.2 8.4 1.97 0.049
OFC – Occipito-frontal circumference; MUAC – Mid-upper arm circumference;
Subscap – Subscapular skinfold thickness; SBP- Systolic blood pressure; DBP-
Diastolic blood pressure.
doi:10.1371/journal.pone.0024548.t002
Table 3. Associations between growth characteristics and blood pressure at birth defined by Parasite density and Timing of
Malaria.
a. Parasite density# b. TIMING of maternal malaria*
Variable Malaria mean D
95% CI of
Difference p-value
+ Malaria mean D
95% CI of
Difference p-value
+
Weight kg None n=225 3.0 0.3 0.1,0.4 0.005 No malaria n=225 3.0 0.1 0.0, 0.2 0.006
Low n=131 3.0 0.3 0.1,0.4 0.005 In pregnancy n=138 2.8 *
High n=80 2.7 # At delivery n=73 2.9 0.1 20.1, 0.2 0.425
Length cm None 49.0 1.1 0.5,1.6 0.001 No malaria 49.0 0.7 0.2, 1.2 0.006
Low 48.6 0.7 0.04,1.3 0.037 In pregnancy 48.3 *
High 47.9 # At delivery 48.5 0.2 20.5, 0.9 0.565
OFC cm None 34.5 0.7 0.3,1.0 ,0.001 No malaria 34.5 0.3 20.0, 0.6 0.065
Low 34.4 0.6 0.3,1.0 0.001 In pregnancy 34.2 *
High 33.8 # At delivery 34.1 20.1 20.4, 0.3 0.792
MUAC mm None 9.9 0.4 0.2,0.6 0.001 No malaria 10.0 0.3 0.0, 0.4 0.024
Low 9.9 0.4 0.1,0.6 0.006 In pregnancy 9.7 *
High 9.5 # At delivery 9.8 0.1 20.1, 0.4 0.388
Sub-scapular None 4.4 0.4 0.0,0.7 0.026 No malaria 4.3 0.2 0.0, 0.4 0.088
mm Low 4.2 0.2 20.1,0.6 0.199 In pregnancy 4.1 *
High 4.0 # At delivery 4.2 0.1 20.2, 0.4 0.467
+Analysis of Variance.
#Reference group=High parasitaemia.
*Reference group=Malaria in pregnancy.
There were no differences between Low parasitaemia and None.
D – Difference; OFC – Occipito-frontal circumference; MUAC – Mid-upper arm circumference; Subs – Subscapular skinfold thickness;
doi:10.1371/journal.pone.0024548.t003
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Malaria.
a. Parasite density# b. TIMING of maternal malaria*
Variable Malaria mean D
95% CI of
Difference p-value
+ Malaria mean D
95% CI of
Difference p-value
+
Triceps mm None 4.2 0.3 0.0,0.5 0.031 No malaria 4.2 0.1 0.0, 0.3 0.139
Low 4.2 0.3 20.2,0.5 0.074 In pregnancy 4.1 *
High 3.9 # At delivery 4.1 0.0 20.2, 0.3 0.453
Biceps mm None 3.7 0.2 0.0,0.4 0.029 No malaria 3.7 0.2 0.0, 0.3 0.024
Low 3.6 0.1 20.1,0.3 0.365 In pregnancy 3.5 *
High 3.5 # At delivery 3.6 0.1 20.1, 0.3 0.446
Suprailiac None 4.4 0.2 20.0, 0.5 0.05 No malaria 4.4 20.1 20.0, 0.4 0.135
mm Low 4.3 0.1 20.1, 0.4 0.26 In pregnancy 4.3 *
High 4.2 # At delivery 4.3 0.0 20.3, 0.3 0.865
Subs/Triceps None 1.0 0.0 20.0, 0.0 0.717 No malaria 1.03 0.0 20.0, 0.0 0.975
Ratio Low 1.0 0.0 20.0, 0.0 0.693 In pregnancy 1.03 *
High 1.0 # At delivery 1.02 20.01 20.0, 0.0 0.857
SBP mmHg None 72.4 3.0 20.4,6.4 0.082 No malaria 72.4 1.4 21.3, 4.3 0.292
Low 69.5 0.1 23.6,3.8 0.956 In pregnancy 71.0 *
High 69.4 # At delivery 66.7 24.3 28.0, 20.6 0.001
DBP mmHg None 37.0 1.0 21.4,3.3 0.442 No malaria 37.0 1.1 20.9, 3.0 0.294
Low 34.7 21.3 23.9,1.3 0.329 In pregnancy 35.9 *
High 36.0 # At delivery 33.9 22.0 24.7, 0.6 0.125
+Analysis of Variance.
#Reference group=High parasitaemia.
*Reference group=Malaria in pregnancy.
There were no differences between Low parasitaemia and None.
D – Difference; Subs – Subscapular skinfold thickness; SBP- Systolic blood pressure; DBP- Diastolic blood pressure.
doi:10.1371/journal.pone.0024548.t004
Table 5. Multiple regression analyses for determinants of birth size including maternal malaria parasite density.
Variable Regression for Birth weight Regression for Birth length
ß 95% CI P-value ß 95% CI P-value
Length (cm) 0.10 0.08 to 0.11 ,0.001 Weight (kg) 2.78 2.29 to 3.28 ,0.001
GA at birth (weeks) 0.04 0.02 to 0.07 0.003 0.07 20.08 to 0.22 0.37
No Malaria (Reference)+ -- - -- -
Low Parasite density+ 20.02 20.10 to 0.07 0.71 20.26 20.70 to 0.17 0.23
High Parasite density+ 20.10 20.20 to 20.00 0.045 20.28 20.81 to 0.25 0.31
Maternal age (years) 0.00 20.01 to 0.01 0.35 0.04 20.01 to 0.09 0.15
Maternal weight (kg) 0.01 0.00 to 0.01 ,0.001 0.01 20.01 to 0.03 0. 45
Maternal height (cm) 20.00 20.01 to20.00 0.22 0.03 20.01 to 0.08 0.09
Maternal SBP (mmHg) 0.00 20.01 to 0.01 0.88 20.01 20.05 to 0.02 0.49
Maternal DBP (mmHg) 20.00 20.01 to 0.01 0.58 20.01 20.05 to 0.03 0.73
Gravidity 20.01 20.05 to 0.02 0.49 20.00 20.20 to 0.20 0.99
Number of Antenatal Visits 0.01 20.01 to 0.03 0.33 0.09 20.04 to 0.21 0.17
GA – Gestational Age; SBP- Systolic blood pressure; DBP- Diastolic blood pressure.
+Parasite density: Coding 0=No Malaria- Reference category,
1=low parasite density; 2=high parasite density.
doi:10.1371/journal.pone.0024548.t005
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adjusted for weight SBP and DBP were higher by 1.7 (0.2,
3.3)mmHg/kg, p=0.024 and 1.4 (0.4, 2.3)mmHg/kg, p=0.006
respectively in babies whose mothers had high parasitaemia
compared to those with low (Table 6).
In regression analyses, newborn SBP was independently
associated with birth weight and gestational age and inversely
associated with birth length and maternal height. Malaria
parasitaemia timing, specifically at delivery was also a determi-
nant of infant SBP (Table 7). Maternal age, weight and DBP were
not. Newborn DBP at birth was positively associated with birth
weight, gestational age and inversely with parasitaemia at
delivery (Table 7).
Discussion
General features of malaria
This study illustrates the continuing impact of malaria in
otherwise healthy pregnant Nigerian women, almost half of whom
(48%) were affected. The rates confirm recent reports in pregnant
Nigerian women [5,21] and are also in agreement with findings
from Malawi, Gabon and Ghana, but lower than in Western
Kenya [22–25]. The latter areas have similar endemic rates to that
in Nigeria. Most of our study cohort was asymptomatic, in line
with previous findings that malaria in pregnancy in Africa rarely
results in fever or any symptoms and therefore remains mostly
undetected and untreated [8].
Table 6. Association between maternal malaria parasite load and newborn SBP and DBP adjusted for birth weight and length.
Variable Malaria Parasite density mean Difference 95% CI of difference p-value+
SBP/weight None 24.8 20.9 20.5, 2.3 0.185
Low 24.0 21.7 20.2, 23.3 0.024
High 25.7
SBP/length None 1.48 0.03 20.11, 0.04 0.417
Low 1.43 20.02 20.06, 0.10 0.663
High 1.45
DBP/weight None 12.6 20.7 20.2,1.7 0.105
Low 12.0 21.4 20.4, 22.3 0.006
High 13.4
DBP/length None 0.75 0.0 20.05, 0.05 0.958
Low 0.72 20.3 20.02, 0.09 0.164
High 0.75
+Analysis of Variance.
SBP- Systolic blood pressure; DBP- Diastolic blood pressure.
doi:10.1371/journal.pone.0024548.t006
Table 7. Multiple regression analyses for determinants of newborn SBP and DBP at birth including maternal malaria timing.
Variable Regression for SBP Regression for DBP
ß 95% CI P-value ß 95% CI P-value
Weight (kg) 8.35 4.36 to12.35 ,0.001 3.07 0.26 to 5.88 0.032
Length (cm) 21.2 21.9 to 20.4 0.003 20.2 20. to 0.3 0.37
GA at birth (weeks) 1.39 0.4 to 2.4 0.009 0.90 0.17 to 1.62 0.016
No Malaria (Reference)* - - - - - -
Malaria in pregnancy* 22.0 25.0 to 1.0 0.19 21.63 23.7 to 0.5 0.13
Malaria at delivery 6 pregnancy* 26.6 210.4 to 2.8 0.001 24.06 26.7 to 21.4 0.003
Maternal age (years) 0.32 20.3 to 0.7 0.07 20.04 20.3 to 0.2 0.73
Maternal weight (kg) 20.06 20.2 to 0.09 0.41 20.01 20.1 to 0.1 0.82
Maternal height (cm) 20.31 20.6 to 20.05 0.02 20.17 20.4 to 0.01 0.06
Maternal SBP (mmHg) 0.19 20.05 to 0.4 0.12 0.07 20.1 to 0.2 0.40
Maternal DBP (mmHg) 20.25 20.5 to 0.04 0.09 0.00 20.2 to 0.2 0.98
Gravidity 20.66 22.0 to0.7 0.33 20.22 21.2 to 0.7 0.64
Number of Antenatal Visits 20.36 21.2 to 0.5 0.40 0.06 20.53 to 0.64 0.84
GA – Gestational Age; SBP- Systolic blood pressure; DBP- Diastolic blood pressure.
*Malarial timing: Coding 0=No Malaria- Reference category 1=malaria in pregnancy, 2=malaria at delivery ± pregnancy.
doi:10.1371/journal.pone.0024548.t007
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against malaria, including the 53% who said they used chemopro-
phylactic drugs, there was no difference in malaria parasitaemia
frequency. Previous findings have shown that netted windows,
insecticide sprays, mosquito repellent and insecticide-treated nets
were effective in protecting against malaria [26,27]. In Nigeria,
there is low use of SP for IPT as recommended for prevention of
malariainpregnancy;thisisduetocost,aswasthecaseinthisstudy.
When used appropriately, IPT with SP is effective in preventing
malaria in pregnancy [28]. In Mali, there was a reduction in the
incidence of LBW among neonates born to women who used IPT
with SP compared to other anti-malarial drugs [29].
In the suburban women in this study, malaria parasitaemia was
not associated with social class, similar to a Kenyan report [24] but
contrasting with those from Burkina Faso and India, with a higher
incidence in low-income groups in rural areas [30,31]. Primigravid
women were more affected by malaria, as described [32], likely
related to protective anti-adhesion antibodies against chondroitin
sulphate A-binding parasites developing only over successive
pregnancies [33].
In this study, diagnosis of malaria was based on microscopy of
peripheral, placental and cord blood samples. Malaria in
pregnancy still presents diagnostic challenges and has relied
mainly on microscopy in studies in sub-Saharan Africa. Micros-
copy, though valuable, requires well-trained and skilled staff [34].
It can be used for speciation and quantification of parasites as
done in this study, as well as assessing response to treatment.
Histological examination, although reported to be more sensitive
than microscopy on placental blood samples [35], was not
available for this study. Placental blood, in addition to peripheral
blood smears, were used to ensure that placental malarial
infections were detected when peripheral parasitaemia may be
negative [36]. Therefore we included all these sites in our
definition of malaria in pregnancy and delivery.
Birth outcomes
Babies of mothers with parasitaemia were globally smaller, most
marked among babies of mothers with high parasite density during
pregnancy. Similarly, mean birth weights in Burkina Faso,
Tanzania, Mali and Pakistan for babies born to mothers with
malaria in pregnancy were lower by 105 gm [37], 371 gm [38],
382 gm [32] and 461 gm [39] than those without malaria. Other
anthropometry was not reported in these studies.
Birth weight is the single most important determinant of
neonatal and infant survival and health, and malaria reduced all
growth parameters, [40] probably related to chronic placental
infection and insufficiency [40,41].
Effects on newborn BP
Some of the mechanisms linking small birth size and adult
hypertension are poor maternal nutrition and maternal iron
deficiency anaemia, which reduces vascular elasticity [42,43]. In
mothers with reduced skinfold thicknesses and lower haemoglobin
concentrations, their children’s SBP at the age of 10–12 years
increased by 2.6 mmHg for each 1 g/dl decline in the mother’s
haemoglobin [42]. This confirms findings in experimental studies,
where maternal iron restriction in the rat reduced birth weight and
led to elevated BP at 40 days of age [44]. In this study anaemia at
32% is lower than previously reported in more rural Southern
Nigeria but higher than rates from the nearby tertiary University
College Hospital, Ibadan, with better obstetric facilities and
managing patients in higher social classes [45,46]. As elsewhere,
anaemia is significantly associated with parasitaemia in primigravid
women [5,47]. These findings support the theory that maternal
anaemia, an important consequence of malaria in pregnancy, could
be linked to the genesis of raised BP in children. In contrast to other
settings [48], maternal age was not associated with newborn BP,
which is generally related to birth weight [49,50].
In this cohort we found that babies whose mothers had malaria
parasitaemia at delivery had lower SBP and DBP (Table 4). This
observation could be accounted for in part by findings of lower
mean BP in LBW babies and higher mean BP in those with higher
birth weight [51], but this may also be related to the acute
haemodynamic effects occurring in placental parasitaemia which
may lead to lower newborn BP.
Overall, malarial load through pregnancy had the greatest
impact on birth size (Table 3). Thus those babies who were
exposed to high parasite loads through pregnancy were the
smallest, and rather than having lower BP, both SBP and DBP
corrected for weight were higher than in those exposed to a low
parasite load (Table 6). This is in keeping with a developmental
origins hypothesis linking placental insufficiency, IUGR and later
hypertension. On-going follow-up will reveal whether small
babies, having been exposed to intra-uterine malaria, who then
show early catch-up growth, will have higher blood pressure. As
far as we are aware, this is the first study to follow such a cohort,
and the recognition of raised BP in early childhood could have
important implications to health in Africa.
This leads to the question of how these two contrasting
observations on BP related to timing and parasite density are
mediated. Our hypothesis is that in these LBW babies, placental
parasitaemia is associated with significant inflammation in the
placental and infant arterial tree leading to more acute placental
changes and significant infant vascular dilatation as an initial
protective mechanism and hence lower BP at birth in those with
parasitaemia at delivery. In contrast, parasitaemia during pregnancy
leads to general growth restriction and smaller birth size and
relativelyhigherBPforsize.The morelimitedvasculartree of lighter
infants may not be able to meet end-organ oxygen and nutritional
demand without reactive peripheral vasoconstriction and higher BPs
over time. Marginally but progressive higher BPs in infancy and
early childhood may result, leading to a higher risk of hypertension
in later life. Recurrent post-natal malaria will intermittently alter
peripheral blood flow, but again at the expense of optimal supply to
particularorgans,hencerestrictinggrowth.Thebalancebetweenthe
overall size of the fetus’ vascular tree, how well particular organs
grow during pregnancy, notably the renal glomeruli with their
afferent and efferent arterioles, and continuing environmental
hazards (e.g. infections, limited food supply and food quality) or
opportunities (e.g. plentiful physical activity) will determine vascular
performance, now measurable by pulse wave velocity [52].
Conclusions
There is a high incidence of malaria and anaemia in this
apparently healthy cohort of pregnant women, particularly the
younger mothers and primigravids. Malaria in pregnancy
adversely affects birth size, with high parasite density during
pregnancy having the greatest impact on all growth parameters
and being associated with higher BP corrected for weight. Follow-
up studies to extend these observations into early childhood and to
provide a better understanding of the influence of maternal
malaria on BP in this cohort are underway.
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